Innovations in the formulation of Amorphous Solid Dispersion 2026
Date
23 October 2026
Subject areas
Industry , Analytical , Chemical Biology and Medicinal
Location
London, UK
The Formulation Science and Technology (FST) Interest Group of the Royal Society of Chemistry is pleased to announce Innovations in the Formulation of Amorphous Solid Dispersions 2026. Building on the success of the inaugural meeting in 2024, this second edition will be held on Friday, 23 October 2026, at the Royal Society of Chemistry, Burlington House, London, United Kingdom.
This scientific event will bring together leading researchers from academia and industry to share the latest innovations in amorphous solid dispersions through invited lectures and poster sessions. We are particularly keen to achieve a strong balance among academics, industrial scientists, and students, creating an excellent environment for scientific discussion, collaboration, and networking.
The seven selected speakers and their topics are listed below:
Ms Carolina Alva Research Center Pharmaceutical Engineering, Graz, Austria Topic: Tailoring the release of highly loaded amorphous solid dispersions via additive manufacturing
Dr Ecaterina Bordos CMAC, University of Strathclyde, United Kingdom Topic: Probing amorphous solid dispersions with synchrotron X-ray phase-contrast tomography
Dr Tetiana Kolisnyk TU Dortmund University, Germany Topic: High-drug-loaded amorphous solid dispersions of a poor glass-forming drug
Dr Peter O’Connell Johnson & Johnson Innovative Medicine, Belgium Topic: Accelerated predictive stability strategies applied to the screening of pharmaceutical formulations and amorphous solid dispersions
Dr Justin Yiwei Tian Queen’s University Belfast, United Kingdom Topic: High-drug-loading nanosized amorphous solid dispersions with enhanced in vitro solubility and permeability
Dr Vivek Trivedi University of Kent, United Kingdom Topic: Felodipine–PEG solid dispersions prepared by solvent-free scCO₂ processing for orally disintegrating tablets
Dr George Papakostas AstraZeneca, United Kingdom Topic: High-throughput amorphous solid dispersion screening using picoliter 2D-Inkjet printed microarrays
Deadlines
Downloads
Speakers
Ms. Carolina Alva
Research Center Pharmaceutical Engineering, Graz
Austria
Dr. Peter O’Connell
Johnson & Johnson Innovative Medicine
Belgium
Dr. Ecaterina Bordos
CMAC, University of Strathclyde
UK
Dr. Justin Yiwei Tian
Queen's University Belfast
UK
Dr. Tetiana Kolisnyk
TU Dortmund University
Germany
Dr. Vivek Trivedi
University of Kent
UK
Dr. George Papakostas
AstraZeneca
UK
Committees
Dr. Bin Yang
AstraZeneca
UK
Dr John Wynne Jones
AstraZeneca
UK
Dr. Patric Wray
Bristol Myers Squibb
UK
Dr. Shashi Ravi Suman Rudrangi
Olema Oncology
UK
Event details
Ten poster bursaries are available on a first-come, first-served basis and will cover the registration fee.
If you would like to register for this conference or present a poster, please email [email protected].
Deadlines
Burlington House, Royal Society of Chemistry
Old library, Burlington House, Royal Society of Chemistry, Piccadilly, London, W1J 0BD, UK